Português | English



EXTRACTA project wins economic grant

EXTRACTA project wins grant to develop economic FAPERJ your anti-tuberculosis extracts.


EXTRACTA isolate the active extract

EXTRACTA isolate the active extract of its anti-MRSA. (methicillin-resistant Staphylococcus aureus).


EXTRACTA renews its CGEN/MMA authorization

The Board of Management of Genetic Resources (Environment Ministry) renews EXTRACTA Special License  without geographical limitations to access the Brazilian Genetic Heritage, aiming to expand its extratoteca Commercial Bank (EXTRACTA Chemical Biodiversity).


EXTRACTA receives 18-month contract from FAPERJ

EXTRACTA as a technology company, receives from FAPERJ (Fundação Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) approval of a contract for 18 months for preclinical development of its extracts inhibiting InhA, potential herbal antituberculosis drugs.


EXTRACTA presents at the Fair Biolatina 2008

EXTRACTA increases its efforts to seek industrial partners for the development of its pipeline, performing at the Fair Biolatina 2008, in São Paulo.

Página anterior | 1  2  3  4  5  6 | Próxima página